Taken together, continuously up-regulated FGFR4 expression in advanced NASH should call attention because hyperactivation of FGFR4 by FGF19 was reported in colon cancer and HCC 37. This evidence concerns the gene FGF19 and metabolic dysfunction-associated steatohepatitis.